RecruitingNot ApplicableNCT06697275

Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device in Children With Leukemia

Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device in Children With Leukemia: Randomized Multicenter Trial


Sponsor

University Hospital, Clermont-Ferrand

Enrollment

120 participants

Start Date

Nov 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Main objective: Evaluate the effectiveness of the repeated use of interactive or hypnotic virtual reality compared to standard treatment, on pain, during each needle placement on PAC for 3 months on children or adolescents (6 to 16 years old) with acute leukemia Hypothesis: Repeated use over 3 months of hypnotic or interactive virtual reality provides more benefits in terms of : * pain management * anxiety of the child and his parents * satisfaction of the child's care, of his parents and of the caregivers compared to the standard method when inserting a needle into an implantable port in the pediatric oncology department or day hospital.


Eligibility

Min Age: 6 YearsMax Age: 16 Years

Inclusion Criteria11

  • Children from 6 to 16 years old suffering from leukemia requiring needle insertion into an implantable port and having a life expectancy greater than or equal to 3 months
  • Subjects and their parents who have been informed of the study and having expressed their informed consent
  • Children without contraindications to the use of MEOPA® :
  • Patient requiring 100% oxygen ventilation
  • Intracranial hypertension
  • Any alteration in the state of consciousness preventing the patient\'s cooperation
  • Children without contraindication to the use of the virtual reality mask:
  • Epilepsy
  • Psychiatric illness
  • Children and parents able to use the self-assessment scales proposed in the study
  • Enrolment in the Social Security system

Exclusion Criteria4

  • Children from 6 to 16:
  • Having a modification of pain\'s integration (spina bifida for example)
  • Requiring contact isolation (conjunctivitis, contagious skin condition, etc.)
  • With a history of seizures

Interventions

DEVICEHypnotic Virtual reality

Hypnotic Virtual reality mask Deepsen® with age-appropriate software Birdy®

DEVICEInteractive virtual reality

Interactive virtual reality mask Deepsen® with age-appropriate software Birdy®

OTHERStandard method

Use of local anesthesic cream + Nurse and/or parents distraction +/- anxioloytic gas


Locations(4)

CHU de Bordeaux

Bordeaux, France

CHU de Clermont-Ferrand

Clermont-Ferrand, France

Assistance Publique - Hôpitaux de Marseille

Marseille, France

CHU de Toulouse

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06697275


Related Trials